ArticleAntibiotics (Basel, Switzerland)2025
Optimising Regimen of Co-Amoxiclav (ORCA)-The Safety and Efficacy of Intravenous Co-Amoxiclav at Higher Dosing Frequency in Patients with Diabetic Foot Infection.
Jun Jie Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.